Pages that link to "Q44028568"
Jump to navigation
Jump to search
The following pages link to CYP3A4 induction by drugs: correlation between a pregnane X receptor reporter gene assay and CYP3A4 expression in human hepatocytes (Q44028568):
Displaying 50 items.
- Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia (Q24558647) (← links)
- Possible drug-drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini review (Q26800015) (← links)
- Lead Optimization in Discovery Drug Metabolism and Pharmacokinetics/Case study: The Hepatitis C Virus (HCV) Protease Inhibitor SCH 503034 (Q27489828) (← links)
- PXR variants: the impact on drug metabolism and therapeutic responses (Q28080023) (← links)
- Alterations of chemotherapeutic pharmacokinetic profiles by drug-drug interactions (Q28710150) (← links)
- Functional evolution of the vitamin D and pregnane X receptors (Q30838213) (← links)
- Pregnane-10,2-carbolactones from a Hawaiian Marine Sponge in the Genus Myrmekioderma (Q31083142) (← links)
- Population pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children. (Q33605816) (← links)
- CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose (Q33613593) (← links)
- Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam (Q33668215) (← links)
- Identification of Clinically Used Drugs That Activate Pregnane X Receptors (Q33725126) (← links)
- On the general mechanism of selective induction of cytochrome P450 enzymes by chemicals: some theoretical considerations (Q33742250) (← links)
- Casopitant: In Vitro Data and SimCyp Simulation to Predict In Vivo Metabolic Interactions Involving Cytochrome P450 3A4 (Q33768358) (← links)
- Development of a common carp (Cyprinus carpio) pregnane X receptor (cPXR) transactivation reporter assay and its activation by azole fungicides and pharmaceutical chemicals. (Q33835410) (← links)
- Relative activation of human pregnane X receptor versus constitutive androstane receptor defines distinct classes of CYP2B6 and CYP3A4 inducers (Q33881813) (← links)
- A mechanistic insight into 3,4-methylenedioxymethamphetamine ("ecstasy")-mediated hepatotoxicity. (Q34239110) (← links)
- Dose-dependent induction of cytochrome P450 (CYP) 3A4 and activation of pregnane X receptor by topiramate (Q34278840) (← links)
- Pregnane X receptor and drug-induced liver injury. (Q34345049) (← links)
- Regulation of porcine hepatic cytochrome p450 - implication for boar taint. (Q34514634) (← links)
- Tissue-specific regulation of pregnane X receptor in cancer development and therapy (Q34545411) (← links)
- Cell-based systems to assess nuclear receptor activation and their use in drug development (Q34553662) (← links)
- Impact of lopinavir-ritonavir or nevirapine on bedaquiline exposures and potential implications for patients with tuberculosis-HIV coinfection (Q34596668) (← links)
- Predicting inductive drug-drug interactions (Q35073283) (← links)
- Making better drugs: Decision gates in non-clinical drug development (Q35158006) (← links)
- Drug-activated nuclear receptors CAR and PXR. (Q35160978) (← links)
- Role of orphan nuclear receptors in the regulation of drug-metabolising enzymes. (Q35607530) (← links)
- Adaptation of high-throughput screening in drug discovery-toxicological screening tests. (Q35719340) (← links)
- Biotransformation of the antiretroviral drug etravirine: metabolite identification, reaction phenotyping, and characterization of autoinduction of cytochrome P450-dependent metabolism (Q35846917) (← links)
- Small-molecule modulators of PXR and CAR. (Q35938150) (← links)
- Therapeutic potential of KCa3.1 blockers: recent advances and promising trends (Q38634615) (← links)
- Mechanism-based inhibition of cytochrome P450 3A4 by therapeutic drugs. (Q36068699) (← links)
- Systems biology in drug safety and metabolism: integration of microarray, real-time PCR and enzyme approaches (Q36120843) (← links)
- Induction of endogenous pathways by antiepileptics and clinical implications (Q36263605) (← links)
- The influence of combination use of CYP450 inducers on the pharmacokinetics of voriconazole: a systematic review (Q36273788) (← links)
- A comprehensive in vitro and in silico analysis of antibiotics that activate pregnane X receptor and induce CYP3A4 in liver and intestine (Q36331220) (← links)
- Fosamprenavir : clinical pharmacokinetics and drug interactions of the amprenavir prodrug (Q36399718) (← links)
- The pregnane X receptor in tuberculosis therapeutics (Q36451492) (← links)
- Synthetic drugs and natural products as modulators of constitutive androstane receptor (CAR) and pregnane X receptor (PXR). (Q36473477) (← links)
- CYP induction-mediated drug interactions: in vitro assessment and clinical implications (Q36485692) (← links)
- PXR and CAR: nuclear receptors which play a pivotal role in drug disposition and chemical toxicity (Q36551142) (← links)
- Cell-based models to study hepatic drug metabolism and enzyme induction in humans (Q36572634) (← links)
- Does cytochrome P450 liver isoenzyme induction increase the risk of liver toxicity after paracetamol overdose? (Q36581240) (← links)
- Rapid clinical induction of hepatic cytochrome P4502B6 activity by ritonavir (Q36593838) (← links)
- A review of the effect of anticonvulsant medications on bone mineral density and fracture risk (Q36605584) (← links)
- Discordant associations between SLCO1B1 521T→C and plasma levels of ritonavir-boosted protease inhibitors in AIDS clinical trials group study A5146. (Q36701911) (← links)
- Pharmacokinetic drug interactions involving 17alpha-ethinylestradiol: a new look at an old drug (Q36718456) (← links)
- Time-dependent CYP inhibition (Q36725214) (← links)
- Pharmacokinetics and drug interactions with zonisamide (Q36744156) (← links)
- The evolving role of drug metabolism in drug discovery and development (Q36749461) (← links)
- Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs (Q36795136) (← links)